GDNFs can contribute to therapy resistance, particularly in the context of targeted therapies and chemotherapy. By activating survival pathways, GDNFs can help cancer cells evade apoptosis induced by treatments. For example, in pancreatic cancer, GDNF has been shown to confer resistance to gemcitabine, a commonly used chemotherapeutic agent.
